Surgical Approach for the Treatment of Hirschsprung Disease Using the Swenson Technique (SMILES)

by palligoelme@gmail.com | Mar 12, 2026 | Clinical Trials

​ Conditions: Hirschsprung Disease Interventions: Procedure: transanal or laparoscopy assisted Swenson coloanal pullthrough Sponsors: University Hospital, Angers Not yet recruiting Conditions: Hirschsprung Disease Interventions: Procedure: transanal or laparoscopy...

Human-AI Uncertainty Callibration for Improved Skin Lesion Segmentation

by palligoelme@gmail.com | Mar 12, 2026 | Clinical Trials

​ Conditions: Skin Lesions Interventions: Other: Base Model; Other: FDM Sponsors: Copenhagen Academy for Medical Education and Simulation; Technical University of Denmark Not yet recruiting Conditions: Skin Lesions Interventions: Other: Base Model; Other: FDM...

Suzetrigine for Non-Mastectomy Breast Surgery

by palligoelme@gmail.com | Mar 11, 2026 | Clinical Trials

​ Conditions: Pain, Acute Postoperative; Breast Disease Interventions: Drug: suzetrigine Sponsors: University of California, San Diego; Vertex Pharmaceuticals Incorporated Not yet recruiting Conditions: Pain, Acute Postoperative; Breast Disease Interventions: Drug:...

An Observational Study of Medical Device, HALD (Heart and Lung Diagnostic) to Obtain Heart and Lung Sound Recordings.

by palligoelme@gmail.com | Mar 11, 2026 | Clinical Trials

​ Conditions: Auscultation of Heart and Lungs Sponsors: SonoHL Recruiting Conditions: Auscultation of Heart and Lungs Sponsors: SonoHL Recruiting 

Early arthroscoPic Stabilization veRsus rehabilitatiOn of the Shoulder in Adolescents With a trauMatic First-time Anterior Shoulder Dislocation ePisode.

by palligoelme@gmail.com | Mar 11, 2026 | Clinical Trials

​ Conditions: Shoulder Dislocation Interventions: Procedure: Arthroscopic stabilization; Other: Rehabilitation including a period of immobilization followed by physical therapy Sponsors: McMaster University Not yet recruiting Conditions: Shoulder Dislocation...

Rivastigmine Transdermal Patches Bioequivalence and Adhesion Assessment

by palligoelme@gmail.com | Mar 11, 2026 | Clinical Trials

​ Conditions: Bioequivalence Study in Healthy Subjects Interventions: Drug: Rivastigmine TDS 9,5 mg/24 h; Drug: Exelon® 9.5 mg/24 h Sponsors: Zodiac Produtos Farmaceuticos S.A. Completed Conditions: Bioequivalence Study in Healthy Subjects Interventions: Drug:...